Tumor necrosis factor alpha/cachectin stimulates eosinophil oxidant production and toxicity towards human endothelium

doi:10.1084/jem.171.6.2025

This Article

	Full Text (PDF, 1305K)
	Alert me when this article is cited
	Citation Map

Services

	Email this article
	Similar articles in this journal
	Similar articles in PubMed
	Alert me to new content in the JEM
	Download to citation manager

Citing Articles

	Citing Articles via HighWire
	Citing Articles via CrossRef
	Citing Articles via Google Scholar

Google Scholar

	Articles by Slungaard, A.
	Articles by Jacob, H. S.
	Search for Related Content

PubMed

	PubMed Citation
	Articles by Slungaard, A.
	Articles by Jacob, H. S.


Social Bookmarking

	What's this?

ARTICLES

Tumor necrosis factor alpha/cachectin stimulates eosinophil oxidant production and toxicity towards human endothelium

A Slungaard, GM Vercellotti, G Walker, RD Nelson and HS Jacob
Department of Internal Medicine, University of Minnesota, Minneapolis 55455.

Eosinophils (EOs) participate in a variety of inflammatory states characterized by endothelial cell damage, such as vasculitis, pneumonitis, and endocarditis. We find that 100 U/ml TNF- alpha/cachectin (TNF), a concentration attainable in the blood of humans with parasitic infestations, stimulates highly purified populations of EOs to damage human umbilical vein endothelial cells (HUVEC), a model of human endothelium. This TNF-dependent EO cytotoxicity is strongly inhibited by heparin and methyprednisolone but unaffected by the platelet-activating factor antagonist BN52012 or scavengers of superoxide anion and H2O2, superoxide dismutase and catalase. However, addition of a physiologically relevant concentration of Br- (100 microM) enhances EO/TNF damage to HUVEC, implicating the possible participation of EO peroxidase (EPO) in the killing mechanism. EOs adherent to FCS-coated plastic wells more than double their production of superoxide anion and the cytotoxic EPO-derived oxidant HOBr when exposed to TNF, showing that TNF activates the respiratory burst of EOs attached to a "physiologic" surface. Unlike PMNs, EOs were not irreversibly activated to kill unopsonized endothelium by previous exposure to TNF, and did not degranulate or upregulate CR3 expression as detected by Mo1 in the presence of 100 U/ml TNF. HUVEC exposed 18 h to TNF were considerably more susceptible to lysis by PMA-activated EOs and reagent H2O2, demonstrating a direct effect of TNF upon endothelium, perhaps through inhibition of antioxidant defenses. These findings suggest that abnormally elevated serum levels of TNF may provoke EOs to damage endothelial cells and thereby play a role in the pathogenesis of tissue damage in hypereosinophilic states.
Add to CiteULike CiteULike Add to Complore Complore Add to Connotea Connotea Add to Del.icio.us Del.icio.us Add to Digg Digg Add to Reddit Reddit Add to Technorati Technorati What's this?

This article has been cited by other articles:

Terrier, B., Piette, A.-M., Kerob, D., Cordoliani, F., Tancrede, E., Hamidou, L., Lebbe, C., Bletry, O., Kahn, J.-E. (2006). Superficial Venous Thrombophlebitis as the Initial Manifestation of Hypereosinophilic Syndrome: Study of the First 3 Cases. Arch Dermatol 142: 1606-1610 [Abstract] [Full Text]
Rangasamy, T., Guo, J., Mitzner, W. A., Roman, J., Singh, A., Fryer, A. D., Yamamoto, M., Kensler, T. W., Tuder, R. M., Georas, S. N., Biswal, S. (2005). Disruption of Nrf2 enhances susceptibility to severe airway inflammation and asthma in mice. JEM 202: 47-59 [Abstract] [Full Text]
Pantano, C., Shrivastava, P., McElhinney, B., Janssen-Heininger, Y. (2003). Hydrogen Peroxide Signaling through Tumor Necrosis Factor Receptor 1 Leads to Selective Activation of c-Jun N-terminal Kinase. J. Biol. Chem. 278: 44091-44096 [Abstract] [Full Text]
McElhinney, B., Poynter, M. E., Shrivastava, P., Hazen, S. L., Janssen-Heininger, Y. M. W. (2003). Eosinophil peroxidase catalyzes JNK-mediated membrane blebbing in a Rho kinase-dependent manner. J. Leukoc. Biol. 74: 897-907 [Abstract] [Full Text]
Eboumbou Moukoko, C., El Wali, N., Saeed, O. K., Mohamed-Ali, Q., Gaudart, J., Dessein, A. J., Chevillard, C. (2003). No Evidence for a Major Effect of Tumor Necrosis Factor Alpha Gene Polymorphisms in Periportal Fibrosis Caused by Schistosoma mansoni Infection. Infect. Immun. 71: 5456-5460 [Abstract] [Full Text]
Henri, S., Chevillard, C., Mergani, A., Paris, P., Gaudart, J., Camilla, C., Dessein, H., Montero, F., Elwali, N.-E. M. A., Saeed, O. K., Magzoub, M., Dessein, A. J. (2002). Cytokine Regulation of Periportal Fibrosis in Humans Infected with Schistosoma mansoni: IFN-{gamma} Is Associated with Protection Against Fibrosis and TNF-{alpha} with Aggravation of Disease. J. Immunol. 169: 929-936 [Abstract] [Full Text]
DUGUET, A., IIJIMA, H., EUM, S.-Y., HAMID, Q., EIDELMAN, D. H. (2001). Eosinophil Peroxidase Mediates Protein Nitration in Allergic Airway Inflammation in Mice. Am. J. Respir. Crit. Care Med. 164: 1119-1126 [Abstract] [Full Text]
Pilette, C., Ouadrhiri, Y., Godding, V., Vaerman, J-P., Sibille, Y. (2001). Lung mucosal immunity: immunoglobulin-A revisited. Eur Respir J 18: 571-588 [Abstract] [Full Text]
Bracke, M., van de Graaf, E., Lammers, J.-W. J, Coffer, P. J, Koenderman, L. (2000). In vivo priming of Fc{alpha}R functioning on eosinophils of allergic asthmatics. J. Leukoc. Biol. 68: 655-661 [Abstract] [Full Text]
Dworski, R. (2000). Oxidant stress in asthma. Thorax 55: 51S-53 [Full Text]
Fahy, O., Hammad, H., Sénéchal, S., Pestel, J., Tonnel, A.-B., Wallaert, B., Tsicopoulos, A. (2000). Synergistic Effect of Diesel Organic Extracts and Allergen Der p 1 on the Release of Chemokines by Peripheral Blood Mononuclear Cells from Allergic Subjects . Involvement of the MAP Kinase Pathway. Am. J. Respir. Cell Mol. Bio. 23: 247-254 [Abstract] [Full Text]
Smyth, R. (2000). Inhaled nitric oxide treatment for preterm infants with hypoxic respiratory failure. Thorax 55: S51-55
Wu, W., Chen, Y., Hazen, S. L. (1999). Eosinophil Peroxidase Nitrates Protein Tyrosyl Residues. IMPLICATIONS FOR OXIDATIVE DAMAGE BY NITRATING INTERMEDIATES IN EOSINOPHILIC INFLAMMATORY DISORDERS. J. Biol. Chem. 274: 25933-25944 [Abstract] [Full Text]
Giembycz, M. A., Lindsay, M. A. (1999). Pharmacology of the Eosinophil. Pharmacol. Rev. 51: 213-340 [Abstract] [Full Text]
TILLIE-LEBLOND, I., PUGIN, J., MARQUETTE, C.-H., LAMBLIN, C., SAULNIER, F., BRICHET, A., WALLAERT, B., TONNEL, A.-B., GOSSET, P. (1999). Balance between Proinflammatory Cytokines and Their Inhibitors in Bronchial Lavage from Patients with Status Asthmaticus. Am. J. Respir. Crit. Care Med. 159: 487-494 [Abstract] [Full Text]
Wang, P., Wu, P., Cheewatrakoolpong, B., Myers, J. G., Egan, R. W., Billah, M. M. (1998). Selective Inhibition of IL-5 Receptor {alpha}-Chain Gene Transcription by IL-5, IL-3, and Granulocyte-Macrophage Colony-Stimulating Factor in Human Blood Eosinophils. J. Immunol. 160: 4427-4432 [Abstract] [Full Text]